Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Merck & Co. (MRK.N)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2021-08-13	76.72	98.00	Buy
2021-12-13	73.42	76.00	Neutral
2022-07-15	94.96	98.00	Neutral
2022-07-29	89.34	97.00	Neutral
2022-10-25	97.71	105.00	Neutral
2023-01-31	107.41	108.00	Neutral
2023-04-24	115.94	117.00	Neutral
2023-10-20	102.67	122.00	Buy
2024-01-17	118.13	135.00	Buy
2024-02-01	126.38	148.00	Buy
2024-07-30	115.25	142.00	Buy
2024-10-09	110.27	136.00	Buy
2024-10-31	102.32	125.00	Buy

Disclosures

Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.